The Scientist

» drug development and microbiology

Most Recent

image: The Human Virome

The Human Virome

By | November 1, 2016

Diverse viruses can be found commingling with human and bacteria cells in and on people’s bodies. Scientists are just beginning to understand how these viruses help and when they can turn pathogenic.

0 Comments

image: Cuban-U.S. Research Collaborations Easier Now

Cuban-U.S. Research Collaborations Easier Now

By | October 18, 2016

President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.

0 Comments

image: Deep-Sea Viruses Destroy Archaea

Deep-Sea Viruses Destroy Archaea

By | October 12, 2016

Viruses are responsible for the majority of archaea deaths on the deep ocean floors, scientists show.

4 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Bacteria and Humans Have Been Swapping DNA for Millennia

Bacteria and Humans Have Been Swapping DNA for Millennia

By | October 1, 2016

Bacteria inhabit most tissues in the human body, and genes from some of these microbes have made their way to the human genome. Could this genetic transfer contribute to diseases such as cancer?

3 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Life Scientists Receive “Genius” Grants

Life Scientists Receive “Genius” Grants

By | September 22, 2016

Among this year’s 23 MacArthur Foundation Fellows are pioneering biologists.

0 Comments

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. National Academies Detail the State of Weed Science
  3. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech